Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Biotech
GSK inks $10.6B Nuvalent buyout to challenge Roche and Pfizer
GSK is buying two near-approval therapies that could challenge lung cancer treatments from Roche, Pfizer and other drugmakers.
Nick Paul Taylor
Jun 9, 2026 4:41am
GSK pledges £44M to UK biotech to explore fibrosis regression
Jun 8, 2026 8:50am
At ASCO 2026, a ‘paradigm shift’ for a rare gut cancer looms
Jun 1, 2026 3:55pm
GSK hep B drug cures one-fifth of patients in ‘major step’
May 28, 2026 4:30am
From R&D to M&A: Big Pharmas showcase ‘measurable impact’ of AI
May 7, 2026 9:10am
GSK pens $1B deal for metabolic oligonucleotide from SiranBio
May 6, 2026 8:04am
